# Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)

> **NCT00431093** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 570 (actual)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** tibolone
- **DRUG:** low-dose estradiol/noresterone

## Key facts

- **NCT ID:** NCT00431093
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 570 (ACTUAL)
- **Last updated:** 2022-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00431093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00431093, "Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00431093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*